Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

PURPOSE: Patients treated with warfarin must adhere to frequent monitoring, dietary restrictions, and complicated dose adjustments. Apixaban, a direct factor Xa inhibitor, is an alternative to warfarin that may reduce patient burdens associated with warfarin therapy. However, there is limited eviden...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Patient Prefer Adherence
Hlavní autoři: Koretsune, Yukihiro, Ikeda, Takanori, Kozuma, Ken, Hirano, Teruyuki, Yasaka, Masahiro, Kida, Makoto, Chachin, Motohiko, Imura, Miki
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735985/
https://ncbi.nlm.nih.gov/pubmed/29290682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S152579
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky